Crossmark

Towards a Transparent, Credible, Evidence-Based Decision-Making Process of New Drug Listing on the Hong Kong Hospital Authority Drug Formulary: Challenges and Suggestions

Crossref DOI link: https://doi.org/10.1007/s40258-017-0339-5

Published Online: 2017-07-12

Published Print: 2018-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wong, Carlos King Ho https://orcid.org/0000-0002-6895-6071
Wu, Olivia https://orcid.org/0000-0002-0570-6016
Cheung, Bernard M. Y. https://orcid.org/0000-0001-9106-7363
Funding

Funding for this research was provided by:

Glasgow/HKU Early Career Mobility Fund
License Information

License valid from 2017-07-12

Document is current

Any future updates will be listed below